| UniProt ID | SNX4_HUMAN | |
|---|---|---|
| UniProt AC | O95219 | |
| Protein Name | Sorting nexin-4 | |
| Gene Name | SNX4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 450 | |
| Subcellular Localization |
Early endosome membrane Peripheral membrane protein Cytoplasmic side . Also detected on a juxtanuclear endocytic recycling compartment (ERC). |
|
| Protein Description | May be involved in several stages of intracellular trafficking. Plays a role in recycling endocytosed transferrin receptor and prevent its degradation.. | |
| Protein Sequence | MEQAPPDPERQLQPAPLEPLGSPDAGLGAAVGKEAEGAGEESSGVDTMTHNNFWLKKIEISVSEAEKRTGRNAMNMQETYTAYLIETRSVEHTDGQSVLTDSLWRRYSEFELLRSYLLVYYPHIVVPPLPEKRAEFVWHKLSADNMDPDFVERRRIGLENFLLRIASHPILCRDKIFYLFLTQEGNWKETVNETGFQLKADSRLKALNATFRVKNPDKRFTDLKHYSDELQSVISHLLRVRARVADRLYGVYKVHGNYGRVFSEWSAIEKEMGDGLQSAGHHMDVYASSIDDILEDEEHYADQLKEYLFYAEALRAVCRKHELMQYDLEMAAQDLASKKQQCEELVTGTVRTFSLKGMTTKLFGQETPEQREARIKVLEEQINEGEQQLKSKNLEGREFVKNAWADIERFKEQKNRDLKEALISYAVMQISMCKKGIQVWTNAKECFSKM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEQAPPDP -------CCCCCCCH | 8.54 | 19413330 | |
| 22 | Phosphorylation | APLEPLGSPDAGLGA CCCCCCCCCCCCCCC | 27.56 | 30266825 | |
| 33 | Ubiquitination | GLGAAVGKEAEGAGE CCCCCCCCCCCCCCC | 47.34 | - | |
| 49 | Phosphorylation | SSGVDTMTHNNFWLK CCCCCCCCCCCEEEE | 24.44 | 30622161 | |
| 54 | Ubiquitination | TMTHNNFWLKKIEIS CCCCCCEEEEEEEEE | 14.92 | - | |
| 56 | Ubiquitination | THNNFWLKKIEISVS CCCCEEEEEEEEEHH | 42.15 | 29967540 | |
| 57 | Ubiquitination | HNNFWLKKIEISVSE CCCEEEEEEEEEHHH | 43.32 | 29967540 | |
| 60 | Ubiquitination | FWLKKIEISVSEAEK EEEEEEEEEHHHHHH | 5.85 | - | |
| 67 | Ubiquitination | ISVSEAEKRTGRNAM EEHHHHHHHHCCCCC | 63.41 | - | |
| 79 | Ubiquitination | NAMNMQETYTAYLIE CCCCHHHHHEEEEEE | 14.85 | - | |
| 89 | Phosphorylation | AYLIETRSVEHTDGQ EEEEEEECEECCCCC | 39.00 | 21712546 | |
| 97 | Phosphorylation | VEHTDGQSVLTDSLW EECCCCCCCCCHHHH | 25.32 | 28857561 | |
| 102 | Phosphorylation | GQSVLTDSLWRRYSE CCCCCCHHHHHHHCH | 25.29 | 24719451 | |
| 107 | Phosphorylation | TDSLWRRYSEFELLR CHHHHHHHCHHHHHH | 12.18 | 23927012 | |
| 108 | Phosphorylation | DSLWRRYSEFELLRS HHHHHHHCHHHHHHH | 33.72 | 28450419 | |
| 108 | Ubiquitination | DSLWRRYSEFELLRS HHHHHHHCHHHHHHH | 33.72 | - | |
| 132 | Ubiquitination | VVPPLPEKRAEFVWH ECCCCCHHHHHHHHH | 55.77 | - | |
| 140 | Ubiquitination | RAEFVWHKLSADNMD HHHHHHHHCCCCCCC | 28.55 | 21906983 | |
| 146 | Sulfoxidation | HKLSADNMDPDFVER HHCCCCCCCHHHHHH | 9.00 | 30846556 | |
| 172 | S-nitrosylation | IASHPILCRDKIFYL HHCCCEECCCCEEEE | 5.68 | 19483679 | |
| 172 | S-nitrosocysteine | IASHPILCRDKIFYL HHCCCEECCCCEEEE | 5.68 | - | |
| 175 | Ubiquitination | HPILCRDKIFYLFLT CCEECCCCEEEEEEE | 18.50 | - | |
| 194 | Ubiquitination | WKETVNETGFQLKAD CCCCCCCCCCEEECH | 37.78 | - | |
| 199 | Ubiquitination | NETGFQLKADSRLKA CCCCCEEECHHHHHH | 39.09 | 21906983 | |
| 205 | Ubiquitination | LKADSRLKALNATFR EECHHHHHHHHEEEE | 50.12 | 27667366 | |
| 205 | Methylation | LKADSRLKALNATFR EECHHHHHHHHEEEE | 50.12 | 115980759 | |
| 210 | Phosphorylation | RLKALNATFRVKNPD HHHHHHEEEEECCCC | 15.76 | - | |
| 211 | Ubiquitination | LKALNATFRVKNPDK HHHHHEEEEECCCCC | 8.64 | - | |
| 216 | Ubiquitination | ATFRVKNPDKRFTDL EEEEECCCCCCCCCH | 42.66 | - | |
| 224 | Ubiquitination | DKRFTDLKHYSDELQ CCCCCCHHHCCHHHH | 43.22 | 21906983 | |
| 226 | Phosphorylation | RFTDLKHYSDELQSV CCCCHHHCCHHHHHH | 19.07 | 29496907 | |
| 231 | Ubiquitination | KHYSDELQSVISHLL HHCCHHHHHHHHHHH | 33.34 | - | |
| 245 | Ubiquitination | LRVRARVADRLYGVY HHHHHHHHHHHCCEE | 7.22 | - | |
| 247 | Methylation | VRARVADRLYGVYKV HHHHHHHHHCCEEEE | 21.77 | 115917457 | |
| 249 | Phosphorylation | ARVADRLYGVYKVHG HHHHHHHCCEEEEEC | 12.87 | 29496907 | |
| 253 | Ubiquitination | DRLYGVYKVHGNYGR HHHCCEEEEECCCCH | 25.91 | 21890473 | |
| 253 | Ubiquitination | DRLYGVYKVHGNYGR HHHCCEEEEECCCCH | 25.91 | 21890473 | |
| 256 | Ubiquitination | YGVYKVHGNYGRVFS CCEEEEECCCCHHHH | 31.85 | - | |
| 263 | Phosphorylation | GNYGRVFSEWSAIEK CCCCHHHHCHHHHHH | 34.99 | 28857561 | |
| 266 | Phosphorylation | GRVFSEWSAIEKEMG CHHHHCHHHHHHHHC | 18.47 | 28857561 | |
| 299 | Ubiquitination | DILEDEEHYADQLKE HHHCCHHHHHHHHHH | 22.49 | - | |
| 304 | Ubiquitination | EEHYADQLKEYLFYA HHHHHHHHHHHHHHH | 4.72 | - | |
| 320 | Ubiquitination | ALRAVCRKHELMQYD HHHHHHHHHHHHHHH | 35.98 | - | |
| 338 | Ubiquitination | AAQDLASKKQQCEEL HHHHHHHHHHHHHHH | 49.33 | 29967540 | |
| 339 | Ubiquitination | AQDLASKKQQCEELV HHHHHHHHHHHHHHH | 43.01 | 29967540 | |
| 347 | Phosphorylation | QQCEELVTGTVRTFS HHHHHHHHCCEEEEE | 39.50 | - | |
| 352 | Phosphorylation | LVTGTVRTFSLKGMT HHHCCEEEEECCCCH | 17.15 | 26434776 | |
| 354 | Phosphorylation | TGTVRTFSLKGMTTK HCCEEEEECCCCHHH | 28.67 | 28857561 | |
| 356 | Methylation | TVRTFSLKGMTTKLF CEEEEECCCCHHHHC | 45.50 | 82991517 | |
| 356 | Ubiquitination | TVRTFSLKGMTTKLF CEEEEECCCCHHHHC | 45.50 | 22817900 | |
| 359 | Phosphorylation | TFSLKGMTTKLFGQE EEECCCCHHHHCCCC | 29.46 | 26434776 | |
| 360 | Phosphorylation | FSLKGMTTKLFGQET EECCCCHHHHCCCCC | 19.50 | 26434776 | |
| 361 | Ubiquitination | SLKGMTTKLFGQETP ECCCCHHHHCCCCCH | 32.43 | 21906983 | |
| 367 | Phosphorylation | TKLFGQETPEQREAR HHHCCCCCHHHHHHH | 25.00 | 25159151 | |
| 376 | Ubiquitination | EQREARIKVLEEQIN HHHHHHHHHHHHHHH | 34.90 | 21906983 | |
| 388 | Ubiquitination | QINEGEQQLKSKNLE HHHHHHHHHHHCCCC | 46.70 | 22817900 | |
| 390 | Ubiquitination | NEGEQQLKSKNLEGR HHHHHHHHHCCCCHH | 55.86 | 21906983 | |
| 391 | Phosphorylation | EGEQQLKSKNLEGRE HHHHHHHHCCCCHHH | 35.05 | 29514088 | |
| 392 | Ubiquitination | GEQQLKSKNLEGREF HHHHHHHCCCCHHHH | 65.06 | 22817900 | |
| 393 | Ubiquitination | EQQLKSKNLEGREFV HHHHHHCCCCHHHHH | 50.87 | 22817900 | |
| 401 | Ubiquitination | LEGREFVKNAWADIE CCHHHHHHHHHHHHH | 46.39 | 21906983 | |
| 408 | Ubiquitination | KNAWADIERFKEQKN HHHHHHHHHHHHHCC | 53.24 | 22817900 | |
| 419 | Acetylation | EQKNRDLKEALISYA HHCCCHHHHHHHHHH | 45.27 | 7851125 | |
| 422 | Ubiquitination | NRDLKEALISYAVMQ CCHHHHHHHHHHHHH | 2.54 | 21963094 | |
| 424 | Ubiquitination | DLKEALISYAVMQIS HHHHHHHHHHHHHHH | 14.11 | 22817900 | |
| 433 | Ubiquitination | AVMQISMCKKGIQVW HHHHHHHCHHCCCHH | 3.08 | 22817900 | |
| 444 | Ubiquitination | IQVWTNAKECFSKM- CCHHCCHHHHHHCC- | 58.02 | - | |
| 449 | Ubiquitination | NAKECFSKM------ CHHHHHHCC------ | 28.51 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SNX4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNX4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNX4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PGFRA_HUMAN | PDGFRA | physical | 9819414 | |
| PGFRB_HUMAN | PDGFRB | physical | 9819414 | |
| INSR_HUMAN | INSR | physical | 9819414 | |
| LEPR_HUMAN | LEPR | physical | 9819414 | |
| EGFR_HUMAN | EGFR | physical | 9819414 | |
| SPT5H_HUMAN | SUPT5H | physical | 21988832 | |
| AR6P1_HUMAN | ARL6IP1 | physical | 25416956 | |
| SNX30_HUMAN | SNX30 | physical | 28514442 | |
| ANKY2_HUMAN | ANKMY2 | physical | 28514442 | |
| ABCBA_HUMAN | ABCB10 | physical | 28514442 | |
| CYBP_HUMAN | CACYBP | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND MASSSPECTROMETRY. | |